Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07147907 · ClinicalTrials.gov registry record
Respiratory Rate Validation Study
A clinical trial, sponsored by Perin Health Devices.
- Completed
- Registry status
- 36
- Enrollment target
NCT07147907: Completed study, sponsored by Perin Health Devices.
NCT07147907 is a clinical trial that has completed, run by Perin Health Devices. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07147907 has completed, sponsored by Perin Health Devices.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to test how accurately a new chest-worn device called the Perin Health Patch measures breathing rate in adults aged 22 and older. The main question it aims to answer is: How accurately does the Perin Health Patch measure breathing rate compared to a standard medical device that measures carbon dioxide in exhaled breath? Participants will: * Wear the Perin Health Patch on their chest during the study session * Breathe through a mouthpiece or nose tube connected to a standard breathing monitor * Follow guided breathing exercises at different speeds (from very slow to fast breathing) using a breathing app * Sit and lie down in different positions during the measurements * Complete the study in one visit lasting about 1-2 hours The study will include both healthy adults and people with conditions like asthma, COPD, heart failure, diabetes, high blood pressure, or obesity to test how well the device works for different types of people. Researchers will compare the breathing rate numbers from the new chest patch to the standard medical device to see if the patch is accurate enough for medical use.
Primary Outcome
The primary outcome is the accuracy of respiratory rate (RR) values reported by the Perin Health Patch compared to respiratory rate measured by manually scored end tidal carbon dioxide (EtCO₂) waveforms from a GE Datex-Ohmeda monitor. Accuracy will be assessed using mean absolute error (MAE), accuracy root mean square (ARMS), bias (mean difference), and standard deviation. Measurements will be collected during multiple stable respiratory rate plateaus (approximately 5-50 breaths per minute) achi
Interventions
- DEVICE Chest Worn Respiratory Rate Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2025-05-05 |
| Est. Completion | 2025-05-22 |
What the finished NCT07147907 record still lists
NCT07147907 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Chest Worn Respiratory Rate Monitor is the first listed.
NCT07147907 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07147907 about?
NCT07147907 is a clinical study titled "Respiratory Rate Validation Study". The goal of this clinical trial is to test how accurately a new chest-worn device called the Perin Health Patch measures breathing rate in adults aged 22 and older. The main question it aims to answer is: How accurately does the Perin Health Patch measure breathing rate compared to a standard medic...
What is the current status of trial NCT07147907?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2025-05-05. Estimated completion is 2025-05-22.
What interventions are being tested in trial NCT07147907?
The interventions under investigation include: Chest Worn Respiratory Rate Monitor (DEVICE).
Who is sponsoring clinical trial NCT07147907?
This trial is sponsored by Perin Health Devices, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI